Significant progress has been made in the production technology of biopharmaceutical centrifuge equipment.

　　In recent years, biopharmaceutical centrifuges have seen significant improvements in performance and reliability, driven by the rapid advancements in microelectronics and mechanical engineering.

　　1. Advanced transmission technology reduces noise and vibration.

　　In the past, biopharmaceutical centrifuges were typically driven by electric motors, while some models relied on high-pressure air currents for power. Since the carbon brushes and commutators of electric motors are major sources of sparking interference, noise, and reduced motor lifespan, in recent years an increasing number of centrifuges have been adopting variable-frequency motors or brushless DC motors. The variable-frequency motor drive not only eliminates the need to replace carbon brushes and avoids carbon dust contamination, but also allows for more precise speed control via a microcomputer-based frequency conversion system. This results in optimized braking and acceleration times, and even at very high rotational speeds, biopharmaceutical centrifuges can significantly reduce noise and vibration levels. To the lowest level. Moreover, the variable-frequency drive method can also save energy. DC motors use position sensors or single-chip microprocessors to achieve motor startup and control, and the wear resistance of motor brushes has been significantly improved—some brush lifespans can reach as long as 4,000 hours.

　　Some biopharmaceutical centrifuges are designed with friction-reducing components and stabilizer sleeves in their drive systems, as well as an electric rapid braking system. These features enable the centrifuge to significantly increase its acceleration during speed-up and slowdown phases and smoothly pass through the rotor’s critical speed, minimizing any system resonance caused by the rotor at its critical speed. Additionally, these centrifuges employ motor-mounted cushioning bases or suspension mounts, flexible couplings, and noise-suppression systems to reduce noise levels, thereby creating a quieter and more comfortable working environment.

　　2. Microcomputer-controlled and computing system, extremely easy to operate.

　　Microcomputers are widely used for control and computation. Users can conveniently select operating parameters as needed, with typically more than nine different acceleration profiles to choose from. The device can store multiple or even numerous application-specific centrifugation programs. The CTR LCD or LED digital display clearly shows, at a glance, the preset values and actual conditions of key parameters such as speed, acceleration, centrifugal force, rotor specifications, and centrifuge chamber temperature. All operational parameters of the biopharmaceutical centrifuge exhibit repeatability. Some centrifuges feature an RS232 standard interface for external computer connection, enabling users to record, set, or modify operational parameters via an external computer. Certain centrifuges can perform relevant calculations and conversions during rotor operation—for example, automatically calculating the corresponding relative centrifugal force (RCF) and implementing deceleration calculations designed to prevent cesium chloride (CsCl) precipitation, as well as automatically optimizing and simulating ideal operating conditions. The oPtima series analytical ultracentrifuges from BECKMAN in the U.S. are equipped with an optical detection system that scans the optical density of samples during separation. These centrifuges are particularly well-suited for applications such as receptor/autoreceptor studies, molecular weight determination, sedimentation coefficient calculation, and bio-pharmaceutical quality control.

　　3. A variety of rotor series for biopharmaceutical centrifuges, catering to different centrifugation applications.

　　As the application fields of centrifuges continue to expand, the variety of rotor types has now grown to over a dozen categories, encompassing hundreds of different models. These include angle rotors, vertical rotors, swinging-bucket rotors, and drum rotors, along with a wide range of tubes and holders, capable of meeting nearly all centrifugation requirements. To enhance user convenience and interchangeability, centrifuge rotors manufactured by Luxiangyi can be used universally across multiple model types. In biopharmaceutical centrifuges, the use of a swinging-bucket rotor shroud significantly reduces air resistance during operation. Under the same motor power consumption, this allows the rotor designed for a 14.4-liter capacity to increase its rotational speed from 3,200 rpm to 4,000 rpm.

　　With the exception of some desktop low-speed centrifuges that use plastic rotors, all centrifuges employ ultra-hard aluminum alloy or titanium alloy as rotor materials. A new forming process utilizes die forging to achieve ultra-high-speed shaping, refining the material’s grain structure and enhancing rotor strength. Machining is performed using five-axis machining centers, which improve both machining accuracy and efficiency.

　　4. Small, efficient refrigeration and vacuum systems

　　Many samples are temperature-sensitive and thus require separation at room temperature or below. The high-efficiency, fluorine-free refrigeration system is compact in size, operates quietly, and does not deplete the atmospheric ozone layer. It enables the centrifuge chamber to maintain a temperature range from -20°C to +40°C, with a tolerance of ±1°C. To reduce air resistance, accelerate reaching the maximum operating speed, quicken the cooling of the rotor, extend the motor’s service life, and ensure precise temperature control, ultracentrifuges, certain high-speed centrifuges, and low-speed large-capacity centrifuges are equipped with vacuum systems. Biopharmaceutical centrifuges come with an automatic vacuum system capable of achieving a vacuum level of 0.5 atmospheres. Currently, centrifuges are also beginning to adopt semiconductor-based refrigeration technology.